TITLE

BETRAYED BY THE BELLY

AUTHOR(S)
Hoag, Hannah
PUB. DATE
September 2002
SOURCE
Discover;Sep2002, Vol. 23 Issue 9, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the spreading of cholera epidemics. Failure of vaccines to be effective against laboratory grown bacteria; Definition of cholera; Collection of stool samples from patients by Andrew Camilli of Tufts University School of Medicine.
ACCESSION #
7222761

 

Related Articles

  • Experts call for vaccination, antibiotics in Haiti.  // Tennessee Tribune;12/16/2010, Vol. 21 Issue 50, p11B 

    The article reports on the need for intensive vaccination and more use of antibiotics to treat people with cholera in Haiti.

  • Two-Year Study of the Protective Efficacy of the Oral Whole Cell plus Recombinant B Subunit... Taylor, David N.; Cardenas, Vicky; Sanchez, Jose L.; Begue, Rodolfo E.; Gilman, Robert; Bautista, Christian; Perez, Juan; Puga, Romulo; Gaillour, Alvaro; Meza, Rina; Echeverria, Peter; Sadoff, Jerald // Journal of Infectious Diseases;5/1/2000, Vol. 181 Issue 5, p1667 

    Examines the protective efficacy of an oral inactivated whole cell (WC) Vibrio cholerae plus recombinant B subunit (BS) cholera vaccine against El Tor cholera among Peruvian children and adults. Prevalence of cholera; Development of the oral vaccine from inactivated whole cell V. cholerae plus...

  • Cholera vaccines.  // Weekly Epidemiological Record;5/4/2001, Vol. 76 Issue 18, p7 

    Presents a corrected reprint of an article previously published in the 2001 issue of the 'Weekly Epidemiological Record.'

  • Oral cholera vaccine raises hopes. Kmietowicz, Zosia // BMJ: British Medical Journal (International Edition);2/1/97, Vol. 314 Issue 7077, p326 

    Reports on the discovery of an oral killed cholera vaccine which is expected to address the epidemic in Vietnam. Efficacy of the vaccine; Advantages of the local oral killed cholera vaccine.

  • Meeting demand for the oral cholera vaccine.  // Bulletin of the World Health Organization;Feb2016, Vol. 94 Issue 2, p80 

    The article reports the approval by the World Health Organization (WHO) as of February 2016 of Korean firm Eubiologics Co., Ltd. as manufacturer of oral cholera vaccines.

  • Vaccine against cholera.  // Presidents & Prime Ministers;Jan/Feb95, Vol. 4 Issue 1, p39 

    Reports on the oral vaccine against cholera developed by the United States Navy's tropical diseases office stationed in Lima's Naval Hospital.

  • Oral cholera vaccines (update).  // Weekly Epidemiological Record;8/2/2002, Vol. 77 Issue 31, p262 

    Presents updates on oral cholera vaccine development as of August 2002. Number of oral cholera vaccines available to date; Vaccine safety; Potential use in emergency situations; Constraints and future challenges to vaccine development.

  • Potential use in emergency situations.  // Weekly Epidemiological Record;8/2/2002, Vol. 77 Issue 31, p263 

    Reports on the potential use of oral cholera vaccines in emergency situations. Progress in vaccine development; Recommendations on the emergency use of the vaccines.

  • Oral cholera vaccines (update).  // Weekly Epidemiological Record;8/2/2002, Vol. 77 Issue 31, p262 

    Presents updates on oral cholera vaccine development as of August 2002. Number of oral cholera vaccines available to date; Vaccine safety; Potential use in emergency situations; Constraints and future challenges to vaccine development.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics